CLEVELAND, Aug. 1, 2023 /PRNewswire/ — Enspire DBS Therapy, Inc., (Enspire) a clinical stage company developing an implantable neuromodulation therapy for post-stroke recovery, announced today that it raised $17.6 million of committed capital in a Series B financing led by existing investor, Cleveland Clinic. Also participating in the round were…Read More
Enspire DBS Therapy Announces 176 Million Series B Financing to Advance the Development of Deep Brain Stimulation DBS plus Rehabilitation for Stroke Patients
